SCIENCE · AI-ASSISTED SUMMARY
One‑Third of Infants Previously Diagnosed with Peanut Allergy Pass Oral Food Challenge
WHY IT MATTERS
The study shows that many infant peanut allergies are transient, allowing families to avoid lifelong avoidance, costly therapy, and the anxiety of accidental exposure, while potentially lowering future allergy risk.
What happened
In a recent Australian study, 35 % of 778 infants who had been diagnosed with peanut allergy failed to react during an oral food challenge, a test that administers up to 2,500 mg of peanut flour under medical supervision. The children, all under 12 months, had previously shown allergic symptoms and positive skin‑prick or blood tests.
The challenge, conducted on average six months after diagnosis, revealed that a substantial proportion of infants’ peanut allergies resolve within the first year. Parents of these children were informed that their children no longer carried an allergy label and could safely reintroduce peanuts at home, eliminating the need for costly two‑year oral immunotherapy programs.
The findings suggest that routine oral food challenges could prevent unnecessary treatment and reduce the long‑term risk of developing a true peanut allergy.
LINKED SOURCES
A third of babies with peanut allergy grow out of it by 1 year old
New Scientist · Alice Klein · Discovery and factual synthesis only; publisher copyright and subscription terms apply
THELAST.NEWS is published by Dmitry Yakushev, Cyprus. Briefs are prepared with the help of AI from linked sources and are not individually reviewed by a human editor unless marked otherwise.